TITLE

Worsening of steatosis and fibrosis progression

AUTHOR(S)
Ratziu V; Saboury M; Poynard T
PUB. DATE
September 2003
SOURCE
Gut;Sep2003, Vol. 52 Issue 9, p1386
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
10631334

 

Related Articles

  • Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Castéra, L.; Hézode, C.; Roudot-Thoraval, F.; Bastie, A.; Zafrani, E.-S.; Pawlotsky, J.-M.; Dhumeaux, D. // Gut;Feb2003, Vol. 52 Issue 2, p288 

    Background and aims: Steatosis, a frequent histological finding in patients with chronic hepatitis C (CHC), has been suggested to influence liver fibrosis progression. The aim of the present study was to evaluate in patients with CHC and paired liver biopsies the relationship between the...

  • Prevalence of Liver Steatosis and Fibrosis and the Diagnostic Accuracy of Ultrasound in Bariatric Surgery Patients. Wu, Jiang; You, Jing; Yerian, Lisa; Shiba, Ayako; Schauer, Philip; Sessler, Daniel // Obesity Surgery;Feb2012, Vol. 22 Issue 2, p240 

    Background: Liver steatosis can progress to fibrosis, cirrhosis, and eventually to end-stage liver disease and hepatocellular carcinoma. We thus determined the prevalence of liver steatosis and fibrosis in patients undergoing bariatric surgery using liver biopsy. We also determined the...

  • HOST AND VIRAL CHARACTERISTICS ASSOCIATED WITH STEATOSIS IN CHRONIC HEPATITIS C.  // Gut;Apr2004 Supplement 3, Vol. 53, pA82 

    Steatosis is a frequent histological finding in chronic hepatitis C virus (HCV); however, the pathophysiology of steatosis and its role in disease progression is controversial. It has been suggested that steatosis is associated with genotype 3 and that steatosis could accelerate progression of...

  • Association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Syed, Shuja Izhar; Sadiq, Saleem // Pakistan Journal of Medical Sciences;Apr2011, Vol. 27 Issue 3, p638 

    Objective: To find out the association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Methodology: This was a prospective study based on liver biopsies of hepatitis C patients. H and E stained slides were examined to determine the histological...

  • Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases. Handa, Priya; Kowdley, Kris V. // Annals of Hepatology: Official Journal of the Mexican Associatio;Jan/Feb2014, Vol. 13 Issue 1, p152 

    The article offers information on hepatic inflammation and fibrosis in chronic liver diseases. Chronic liver injury is said to be characterized by inflammation and fibrosis. Hepatocellular carcinoma and end-stage liver disease can be caused by unresolved progression of fibrosis. Chronic...

  • STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER? Asselah, T.; Rubbia-Brandt, L.; Marcellin, P.; Negro, F. // Gut;Jan2006, Vol. 55 Issue 1, p123 

    Hepatic steatosis is a common histological feature of chronic hepatitis C. Various factors are associated with hepatic steatosis, including obesity, high alcohol consumption, diabetes type II, and hyperlipidaemia. These factors may contribute to steatosis in patients with chronic hepatitis C. In...

  • Impact of Steatosis on Insulin Secretion in Chronic Hepatitis C Patients. Narita, Ryoichi; Abe, Shintaro; Tabaru, Akinari; Otsuki, Makoto // American Journal of Gastroenterology;Oct2007, Vol. 102 Issue 10, p2173 

    OBJECTIVES: Liver steatosis is frequently observed in patients with chronic hepatitis C (CHC) and is an identified risk factor for progression of liver fibrosis. This study aimed to evaluate the relationship between steatosis and host/viral factors, and the correlation between steatosis and...

  • Genetic variants in candidate genes influencing NAFLD progression. Rosa, Michelino; Malaguarnera, Lucia // Journal of Molecular Medicine;Feb2012, Vol. 90 Issue 2, p105 

    Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder including simple steatosis and nonalcoholic steatohepatitis (NASH). Advanced stages of NASH result ultimately in fibrosis, cirrhosis, and hepatocarcinoma. A diagnosis of NASH entails an increased risk of both liver-related and...

  • Quantification of portal-bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C. Sandrini, Jérémy; Boursier, Jérôme; Chaigneau, Julien; Sturm, Nathalie; Zarski, Jean-Pierre; Le Bail, Brigitte; de Ledinghen, Victor; Calès, Paul; Rousselet, Marie-Christine // Modern Pathology;Jul2014, Vol. 27 Issue 7, p1035 

    No abstract available.

  • Hepatic steatosis: A benign disease or a silent killer. El-Zayadi, Abdel-Rahman // World Journal of Gastroenterology;7/14/2008, Vol. 14 Issue 26, p4120 

    Steatosis is a common feature of many liver diseases, namely non-alcoholic steatohepatitis (NASH) and hepatitis C virus (HCV) infection, but the pathogenic mechanisms differ. Insulin resistance (IR), a key feature of metabolic syndrome, is crucial for NASH development, associated with many...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics